SEC Form 4 · accession 0001213900-16-013225
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nadav Kidron
Officer — President and CEO · Director · 10% Owner
Period of report
May 12, 2016
Accepted (ET)
May 12, 2016 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2016 | P | 300 | $6.90 | A | 957,448 | D | |
| Common Stock | May 12, 2016 | P | 300 | $6.91 | A | 957,748 | D | |
| Common Stock | May 12, 2016 | P | 300 | $7.00 | A | 958,048 | D | |
| Common Stock | May 12, 2016 | P | 100 | $7.10 | A | 958,148 | D |
Table II — derivative securities
No Table II lines on this filing.